Training | 2020.12.09
PathAI Present Machine Learning Models that Predict the Homologous Recombination Deficiency Status of Breast Cancer Biopsies at the 2020 SABCS
Artificial intelligence (AI)-powered machine learning (ML) models were trained to identify homologous recombination deficiency (HRD) directly from hematoxylin and eosin (H&E)-stained breast cancer tumor biopsy slides from the cancer genome atlas (TCGA), and performed with high accuracy.
(PRWeb December 09, 2020)
Read the full story at https://www.prweb.com/releases/pathai_present_machine_learning_models_that_predict_the_homologous_recombination_deficiency_status_of_breast_cancer_biopsies_at_the_2020_sabcs/prweb17600470.htm
For more information, please visit
https://www.prweb.com/releases/pathai_pr[...]e_2020_sabcs/prweb17600470.htm
